On Friday, the Drug Controller General of India (DCGI) gave it's approval for the emergency use authorisation (EUA) to Zydus Cadila's three-dose COVID-19 vaccine ZyCoV-D. It is the only needle-free vaccine in the world.
More importantly, this vaccine will be the first vaccine to be available for age group 12-18 in India.
Interim results from Phase-III Clinical trials in July with over 28,000 volunteers showed a primary efficacy of 66.6 % for symptomatic RT-PCR positive cases.
This is now the sixth vaccine after Covishield, Covaxin, Sputnik V, Moderna and Johnson & Johnson's single-shot vaccine, to get approval for EUA. As of Friday nearly 57 Crore doses have been administered in India.
0 Comments